5PXU | Transcription | date | Feb 08, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Pandda Analysis Group Deposition -- Crystal Structure Of Sp1 Initial Refinement With No Ligand Modelled (Structure 54) | ||||||||||||||
authors | N.M.Pearce, T.Krojer, R.Talon, A.R.Bradley, M.Fairhead, R.Sethi, N E.Maclean, P.Collins, J.Brandao-Neto, A.Douangamath, Z.Renjie, A J.Ng, P.E.Brennan, O.Cox, C.Bountra, C.H.Arrowsmith, A.Edwards, F Delft | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Nuclear Autoantigen Sp-100 Chain: A, B Synonym: Nuclear Dot-Associated Sp100 Protein,Speckled 100 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Sp100 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: C 1 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.76 Å | ||||||||||||
ligand | EDO, MES, ZN | enzyme |
| ||||||||||||
Primary reference | A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density., Pearce NM, Krojer T, Bradley AR, Collins P, Nowak RP, Talon R, Marsden BD, Kelm S, Shi J, Deane CM, von Delft F, Nat Commun. 2017 Apr 24;8:15123. doi: 10.1038/ncomms15123. PMID:28436492 |
Data retrieval |
View 5PXU in 3D |
Visual 3D analysis of 5PXU |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5PXU |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |